ResearcherUniversity of MiamiActive in the last 2 years
Bach Ardalan
Matched on ORCID iD 0000-0003-3950-1710; OpenAlex author ID A5043198546. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 5
- Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-24-3149↗
- Metastatic Pancreatic Adenocarcinoma Downstaged to T0N0 with Chemotherapy and Targeted Therapy, Confirmed by Surgical Pathology: A Case Report. Co-author DOI 10.1159/000539776↗
- Pancreatic cancer presenting as bowel obstruction and role of next generation sequencing: A case report. Co-author DOI 10.1016/j.ijscr.2021.106654↗
- Cobimetinib Plus Gemcitabine: An Active Combination in KRAS G12R-Mutated Pancreatic Ductal Adenocarcinoma Patients in Previously Treated and Failed Multiple Ch… Co-author DOI 10.1089/pancan.2021.0006↗
- Potential benefit of treatment with MEK inhibitors and chemotherapy in BRAF-mutated KRAS wild-type pancreatic ductal adenocarcinoma patients: a case report. Co-author DOI 10.1101/mcs.a006108↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jonathan S. England · 3 shared papers, 2021–2024 · strength 0.66
- Paper Metastatic Pancreatic Adenocarcinoma Downstaged to T0N0 with Chemotherapy and Targeted Therapy, Confirmed by Surgical P… DOI 10.1159/000539776↗
- Paper Pancreatic cancer presenting as bowel obstruction and role of next generation sequencing: A case report. DOI 10.1016/j.ijscr.2021.106654↗
- Paper Potential benefit of treatment with MEK inhibitors and chemotherapy in BRAF-mutated KRAS wild-type pancreatic ductal ad… DOI 10.1101/mcs.a006108↗
- Danny Sleeman · 2 shared papers, 2021–2024 · strength 0.46
- Paper Metastatic Pancreatic Adenocarcinoma Downstaged to T0N0 with Chemotherapy and Targeted Therapy, Confirmed by Surgical P… DOI 10.1159/000539776↗
- Paper Cobimetinib Plus Gemcitabine: An Active Combination in KRAS G12R-Mutated Pancreatic Ductal Adenocarcinoma Patients in P… DOI 10.1089/pancan.2021.0006↗
- Rene Hartmann · 1 shared paper, 2022 · strength 0.22
- Harshabad Singh · 1 shared paper, 2025 · strength 0.21
- Rachna T. Shroff · 1 shared paper, 2025 · strength 0.21
- Emil Lou · 1 shared paper, 2025 · strength 0.21
- Andrew J. Aguirre · 1 shared paper, 2025 · strength 0.21
- Anup Kasi · 1 shared paper, 2025 · strength 0.21
- Anthony Frank Shields · 1 shared paper, 2025 · strength 0.21
- Michael Jon Pishvaian · 1 shared paper, 2025 · strength 0.21
- Aaron Ciner · 1 shared paper, 2025 · strength 0.21
- Jashodeep Datta · 1 shared paper, 2025 · strength 0.21
- Sanjay Goel · 1 shared paper, 2025 · strength 0.21
- Tiffany Alyssa Eatz · 1 shared paper, 2021 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.